Janux Therapeutics (JANX) Profit After Tax: 2020-2025
Historic Profit After Tax for Janux Therapeutics (JANX) over the last 6 years, with Sep 2025 value amounting to -$24.3 million.
- Janux Therapeutics' Profit After Tax rose 13.35% to -$24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.9 million, marking a year-over-year decrease of 68.32%. This contributed to the annual value of -$69.0 million for FY2024, which is 18.36% down from last year.
- Per Janux Therapeutics' latest filing, its Profit After Tax stood at -$24.3 million for Q3 2025, which was up 28.19% from -$33.9 million recorded in Q2 2025.
- Janux Therapeutics' 5-year Profit After Tax high stood at -$2.3 million for Q1 2021, and its period low was -$33.9 million during Q2 2025.
- In the last 3 years, Janux Therapeutics' Profit After Tax had a median value of -$17.5 million in 2023 and averaged -$19.0 million.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 757.17% in 2021, then spiked by 65.96% in 2024.
- Over the past 5 years, Janux Therapeutics' Profit After Tax (Quarterly) stood at -$13.4 million in 2021, then dropped by 19.75% to -$16.1 million in 2022, then rose by 26.81% to -$11.8 million in 2023, then slumped by 71.93% to -$20.2 million in 2024, then rose by 13.35% to -$24.3 million in 2025.
- Its last three reported values are -$24.3 million in Q3 2025, -$33.9 million for Q2 2025, and -$23.5 million during Q1 2025.